Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMIGO antibiotic pharmacokinetics in obese versus normal-weight adults
NL-OMON46981Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jul 2016
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gentamicin, tobramycin, vancomycin and ciprofloxacin in bacterial disease (4 cohorts), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Clearance of gentamicin, Clearance of tobramycin and 7 more. Started Jul 2016; status: active, not recruiting.
02
Drugs
gentamicintobramycinvancomycinciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON46981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46981.